Skip to main content
. 2011 Jul;163(6):1263–1275. doi: 10.1111/j.1476-5381.2011.01310.x

Figure 1.

Figure 1

Identification of N-(4-hydroxyphenyl)retinamide (4-HPR) metabolites in plasma of 4-HPR-treated patients and mice. (A) HPLC chromatograms showing metabolite peaks in humans (H2–H8, left) and mice (M1–M7, right). Pre-4-HPR (blue), after 4-HPR (red). (B) Structural identification of H2–H8 and M1–M7 via tandem mass spectrometry (MS/MS). Dehydration that occurred during fragmentation of M1, H2/M2, H5/M5 and H8 is likely to involve the hydroxyl (-OH) group highlighted with red box.